Hyloris And Purna Strike Value-Added Development Deal
Miconazole And Domiphen Bromide Combination Will Treat Vulvovaginal Candidiasis
Value-added medicines specialist Hyloris has struck a deal worth up to €4.3m with Purna Female Healthcare to develop a treatment for vulvovaginal candidiasis that combines miconazole and domiphen bromide.